BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management
- 1 July 2017
- journal article
- conference paper
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 37 (4), 1005-1023
- https://doi.org/10.1148/rg.2017160144
Abstract
Harmful mutations of the BRCA tumor suppressor genes result in a greater lifetime risk for malignancy—breast and ovarian cancers in particular. An increased risk for male breast, fallopian tube, primary peritoneal, pancreatic, prostate, and colon cancers also has been reported. The BRCA gene is inherited in an autosomal dominant pattern and tends to be highly penetrant; thus, there is an increased incidence of these cancers in affected families. Compared with sporadic tumors, BRCA-associated malignancies have unique manifestations, clinical features, and pathologic profiles. Manifestation at an early patient age, high-grade tumors, and an aggressive clinical course are common features of BRCA-associated malignancies. Understanding the behavior of these cancers aids in identification of affected individuals and families, who can then make informed decisions regarding their future health. Enhanced screening, prophylactic surgery, and chemoprevention are options for managing cancer risk factors in these individuals. Imaging has an important role in the screening, evaluation, staging, and follow-up of BRCA-associated malignancies. Supplemental screening of BRCA mutation carriers often begins at an early age and is critical for early and accurate cancer diagnoses. The authors review the etiopathogenesis and imaging features of BRCA-associated malignancies, the importance of a multidisciplinary approach to determining the diagnosis, and the treatment of patients who have these mutations to improve their outcomes. © RSNA, 2017This publication has 86 references indexed in Scilit:
- Long-term results of screening with magnetic resonance imaging in women with BRCA mutationsBritish Journal of Cancer, 2012
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)Cancer Epidemiology, Biomarkers & Prevention, 2012
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysisEuropean Journal of Cancer, 2010
- Breast tumor characteristics of BRCA1 and BRCA2 gene mutation carriers on MRIEuropean Radiology, 2008
- Diagnostic Accuracy of Digital versus Film Mammography: Exploratory Analysis of Selected Population Subgroups in DMISTRadiology, 2008
- Breast Cancer Risk Among Male BRCA1 and BRCA2 Mutation CarriersJNCI Journal of the National Cancer Institute, 2007
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Microcalcifications Associated with Breast Cancer: An Epiphenomenon or Biologically Significant Feature of Selected Tumors?Journal of Mammary Gland Biology and Neoplasia, 2005
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesAmerican Journal of Human Genetics, 2003